Physician profile
Boxiang Jiang
NPI 1730541657
$5,217.04
in general payments reported to CMS, 2019-2025
15 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2021: $429 · 2022: $2,106 · 2023: $355 · 2024: $641 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028 · Travel and Lodging: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.03 |
| Travel and Lodging | $389.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,106.74 | 2021-2023 | Signia |
| Intuitive Surgical, INC. | $1,233.51 | 2025 | |
| Davol INC. | $553.12 | 2019-2024 | Progel Applicator Spray Tips |
| Boston Scientific Corporation | $232.95 | 2021-2024 | Spyglass Discover |
| Ethicon US, LLC | $222.27 | 2024 | Surgicel Nu-Knit, Echelon Flex |
| Abbott Laboratories | $186.61 | 2023 | Epic |
| Atricure, INC. | $149.44 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $135.50 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $127.28 | 2024 | Advantagerib |
| La Jolla Pharmaceutical Company | $120.00 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $60.81 | 2025 | Breztri, Imfinzi |
| United Therapeutics Corporation | $29.19 | 2025 | Tyvaso |
| Ethicon INC. | $22.23 | 2024 | Monarch Platform |
| Bard Peripheral Vascular, INC. | $19.90 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.49 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boxiang Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.